DXC Technology Reports Mixed Q3 Results, Faces Substantial IRS Tax Liability, and Secures Major Litigation Win
DXC sits 18% above its 52-week low of $11.82.
Summary
DXC Technology reported a 4.3% organic revenue decline in Q3 FY26 but saw GAAP EPS increase and strong free cash flow. The company faces a potential $569 million IRS tax liability while also securing a $194 million litigation award, alongside active debt reduction and share repurchases.
Key Events · Earnings and Guidance · DXC
-
Q3 FY26 Financial Performance
Organic revenue declined by 4.3% year-over-year, while GAAP diluted EPS increased to $0.61 from $0.31 in the prior-year period. Adjusted diluted EPS grew modestly to $0.96 from $0.92.
-
Substantial IRS Tax Litigation Risk
The company faces a potential $569 million in federal and state tax expense and $652 million in cash payments from ongoing IRS disputes, currently being contested in the U.S. Tax Court.
-
TCS Litigation Award Affirmed
A $194 million monetary award against Tata Consultancy Services was affirmed by the Court of Appeals in November 2025, though it is not yet recognized in financials and is subject to potential Supreme Court review.
-
Strong Free Cash Flow & Capital Management
Year-to-date free cash flow reached $603 million. DXC repurchased $190 million in shares and reduced total debt by $252 million, maintaining $4.7 billion in total liquidity.
Analysis · DXC · Technology
DXC Technology's latest 10-Q filing reveals a mixed financial performance for Q3 FY26, with organic revenue declining by 4.3% year-over-year, indicating ongoing operational challenges. Despite this, the company reported a significant increase in GAAP diluted EPS to $0.61 and strong year-to-date free cash flow of $603 million. The filing highlights a critical contingent liability: potential federal and state tax expenses of $569 million and cash payments of $652 million from ongoing IRS disputes, which represents a substantial risk to the company's financial position. Conversely, a significant positive development is the affirmation of a $194 million monetary award in the TCS litigation, although this amount is not yet recognized in the financial statements and remains subject to further legal proceedings. The company also actively managed its capital, repurchasing $190 million in shares and reducing total debt by $252 million, while extending its revolving credit facility to maintain robust liquidity. Investors should closely monitor the outcomes of the IRS and TCS litigations, as these could materially impact future financial results.
At the time of this filing, DXC was trading at $14.00 on NYSE in the Technology sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $11.82 to $23.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.